Company Profile

Ergo Health LLC
Profile last edited on: 1/28/20      CAGE: 78DM9      UEI: D8XZBJJB1P47

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2018
First Award
2019
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

PO Box 15652
Boston, MA 02215
   (617) 863-7367
   info@ergo-health.com
   www.ergo-health.com
Location: Single
Congr. District: 04
County: Middlesex

Public Profile

Offered for sale by Ergo Health as a powerful anti-oxidant to mitigate damage from environmental stress​, Ergothioneine reduces immune cells accumulation inside of blood vessels. The effect is to avert the development of atherosclerosis - effectively offering a level of protection against cardiovascular disorders such as heart attack and stroke. By scavenging reactive oxygen and nitrogen species, Ergothioneine prevents these harmful molecules from damaging healthy tissues, especially in: red blood cells, bone marrow, the liver, kidneys, the eye and seminal fluid.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $225,000
Project Title: Production Scale-Up and Target Identification of the Antioxidant Ergothioneine

Key People / Management

  Aaron Colby -- CEO

  Mark Grinstaff -- Chairman & Co-Founder

  Pinghua Liu -- President & Co-Founder

Company News

There are no news available.